TABLE 2

Metabolic parameters of mice in both control and indomethacin-treated groups

Metabolic ParameterControlIndomethacinP value
Body weight (g)30.73 ± 1.5731.30 ± 2.040.41
Body composition
 Fat mass (%)19.62 ± 3.0513.32 ± 3.070.23
 Lean mass (%)79.51 ± 3.1983.47 ± 2.880.20
 BAT of body weight (%)0.32 ± 0.010.28 ± 0.160.03
 rWAT of body weight (%)0.95 ± 0.170.81 ± 0.250.34
 eWAT of body weight (%)3.41 ± 0.642.25 ± 0.660.14
 iWAT of body weight (%)1.24 ± 0.381.29 ± 0.090.44
 Food intake (g/day)2.91 ± 0.163.02 ± 0.180.34
 Fasting glucose (mg/dl)229.30 ± 6.84185.00 ± 13.580.02
Blood lipid profile
 TG (mg/dl)95.00 ± 5.0085.00 ± 2.890.07
 TC (mg/dl)160.00 ± 32.79133.30 ± 11.670.24
 LDL-C (mg/dl)63.33 ± 28.4841.67 ± 7.270.25
 VLDL-C (mg/dl)18.33 ± 1.6716.67 ± 1.670.26
 HDL-C (mg/dl)77.50 ± 5.3574.67 ± 4.510.35
 NEFA (nm/ml)13.97 ± 0.4913.88 ± 1.180.47
  • All data are expressed as mean ± SEM (n=3) and analyzed by student t tests. Abbreviations: rWAT, retroperitoneal white adipose tissue; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NEFA, nonesterified fatty acids; TC, total cholesterol; TG, triglyceride; VLDL-C, very low-density lipoprotein cholesterol.